According to the new market research report "Hematology
Analyzers and Reagents Market by Products & Services [Hematology Analyzers
(5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology],
Price Range (High, Low), End User (Government labs) – Global Forecast to
2025", published by MarketsandMarkets™, the Hematology Analyzers and
Reagents Market is projected to reach USD 10.6
billion by 2025 from USD 7.6 billion in
2020, at a CAGR of 6.9% during the forecast period.
Browse in-depth TOC on "Hematology Analyzers and Reagents Market"
199 – Tables
30 – Figures
206 – Pages
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153222146
The increasing incidence of blood disorders and the
growth in the number of blood donation are the major factors driving the growth
of the global hematology analyzers and reagents market. Technological
advancements in hematology analyzers and reagents and the integration of flow
cytometry techniques with hematology analyzers are also expected to support the
growth of this market during the forecast period.
The hematology products & services segment is
expected to register the highest growth rate during the forecast period.
On the basis of products & services, the
hematology analyzers and reagents market is classified into hematology,
hemostasis, and immunohematology products & services. The hematology
products & services segment is projected to grow at the highest growth rate
during the forecast period. Factors such as the increasing adoption of POC
testing hematology analyzers in emerging economies, the launch of
technologically advanced hematology products, the increasing preference for
automation, the growing trend of the "reagent rental" business model,
and the rising availability of a wide range of services from major hematology
providers are driving the growth of this segment.
Based on end user, the commercial service providers
segment accounted for the largest share of the market in 2019.
By end user, the hematology analyzers and reagents
market is segmented into hospital laboratories, commercial service providers,
government reference laboratories, and research & academic institutes. In
2019, the commercial service providers segment accounted for the largest share
of the market due to factors such as the increasing awareness about hematology
testing, shift from manual testing to automated testing, and the competitive
benefits offered by these providers as compared to hospitals (such as
affordable service costs, efficient turnaround time, and efficient management
of sample collection).
Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=153222146
North
America dominated the hematology analyzers and
reagents market in 2019.
North
America accounted for the largest share of the market
in 2019. This can be attributed to the rising incidence of patients suffering
from blood disorders, the growing prevalence of target diseases, and the rising
demand for blood transfusions in the region.
The major players in the global hematology analyzers
and reagents market are Sysmex Corporation (Japan),
Abbott Laboratories (US), Danaher Corporation (US), Nihon Kohden (Japan),
Siemens (Germany),
Boule Diagnostics (Sweden),
HORIBA (Japan),
Bio-Rad Laboratories (US), BioSystems (Spain),
Diatron (Hungary),
Drew Scientific (US), EKF Diagnostics (UK), Mindray (China),
Ortho Clinical Diagnostics (US), and Roche (Switzerland).
Browse Related Reports:
In Vitro Diagnostics Market by
Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry,
Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes,
Oncology, Cardiology, Nephrology) - Forecast to 2023 https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
No comments:
Post a Comment